PDS Biotechnology Corporation (PDSB) Social Stream
PDS BIOTECHNOLOGY CORP (PDSB) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering PDSB.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-05-13 | 5 | $25 | $15 | $20.4 | $5.28 | 286.36% |
| 2022-10-26 | 5 | $25 | $15 | $20.6 | $5.28 | 290.15% |
| 2022-11-01 | 6 | $25 | $10 | $18.833 | $5.28 | 256.69% |
| 2022-11-18 | 6 | $25 | $10 | $18.428 | $5.28 | 249.02% |
| 2022-12-28 | 6 | $25 | $12 | $18.714 | $5.28 | 254.43% |
| 2023-01-03 | 6 | $25 | $12 | $19.571 | $5.28 | 270.66% |
| 2023-03-29 | 5 | $25 | $12 | $20.166 | $5.28 | 281.93% |
| 2023-04-24 | 5 | $25 | $12 | $19.166 | $5.28 | 262.99% |
| 2023-05-16 | 5 | $25 | $12 | $19.8 | $5.28 | 275% |
| 2023-08-15 | 5 | $25 | $14 | $20 | $5.28 | 278.79% |
The Trend in the Analyst Price Target
Over the past 33 weeks, PDSB's average price target has gone up $1.49.
Over the past 42 weeks, PDSB's average upside potential has been 185.96%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-01-03 | 5 | 25 | 12 | 19.571 | 10.62 | 84.28% |
| 2023-01-03 | 5 | 25 | 12 | 20.166 | 10.62 | 89.89% |
| 2023-04-24 | 5 | 25 | 12 | 19.166 | 6.33 | 202.78% |
| 2023-05-16 | 5 | 25 | 12 | 19.800 | 6.77 | 192.47% |
| 2023-06-07 | 5 | 25 | 14 | 20.200 | 5.91 | 241.79% |
PDSB Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 5 | 0 | 0 | 0 | 0 | 5 |
The Trend in the Broker Recommendations
Over the past 30 weeks, PDSB's average broker recommendation rating improved by 0.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In terms of how PDS BIOTECHNOLOGY CORP fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is higher than 1324.28% of that group.
- In terms of how PDS BIOTECHNOLOGY CORP fares relative to all US stocks, note that its number of analysts covering the stock is greater than 363.05% of that group.
- PDSB has a higher average analyst price target than 370.79% of all US stocks.
- PDS BIOTECHNOLOGY CORP's variance in analysts' estimates is lower than -950.9% of all US stocks.
In the Pharmaceutical Products industry, EPIX, ALPN, and VKTX are the three stocks most similar to PDS BIOTECHNOLOGY CORP regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Is PDSB a Buy, Hold or Sell? See the POWR Ratings now!